Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 199 (2), 265-273
- https://doi.org/10.1016/j.expneurol.2006.01.018
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic miceBrain, 2005
- Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease InterventionJournal of Neuroscience, 2004
- Molecular Genetics of Late‐Onset Alzheimer's DiseaseAnnals of Human Genetics, 2004
- Endogenous Glucocorticoids Are Essential for Maintaining Prefrontal Cortical Cognitive FunctionJournal of Neuroscience, 2004
- Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's diseaseThe FASEB Journal, 2004
- Kinetics of Amyloid β-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-based AssaysJournal of Biological Chemistry, 2003
- Transcriptional inhibition of the human insulin receptor gene by aldosteroneThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- RosiglitazoneDrugs, 2002
- Glucocorticoids and insulin resistance: old hormones, new targetsClinical Science, 1999
- Degradation of Amyloid β-Protein by a Metalloprotease Secreted by Microglia and Other Neural and Non-neural CellsJournal of Biological Chemistry, 1997